- Home
- GLBS vs RNXT Comparison
GLBS vs RNXT Comparison
Compare GLBS & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLBS | RNXT |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.0M | 37.4M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GLBS | RNXT |
|---|---|---|
| Price | $2.15 | $0.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.00 | ★ $8.00 |
| AVG Volume (30 Days) | 67.4K | ★ 154.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.60 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $43,000.00 |
| Revenue This Year | $24.03 | $2,995.35 |
| Revenue Next Year | $13.92 | $219.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.70 |
| 52 Week High | $2.12 | $1.45 |
Technical Indicators
Market Signals| Indicator | GLBS | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | 68.96 | 42.70 |
| Support Level | $1.06 | $0.89 |
| Resistance Level | N/A | $1.07 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 100.00 | 19.54 |
Price Performance
Historical ComparisonAbout GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.